Rafarma Pharmaceuticals, Inc. (RAFA) Growing to Play a Major Role in Expanding Russian Pharmaceutical Industry
With over half of the global pharmaceutical market share being controlled by the top 20 companies, primarily American or European, together with the astronomical cost of many critical drugs, it would seem to many that Big Pharma runs the world. It’s easy to understand why the Russian government, working to transition their economy to a more competitive capitalist model, would recognize the need for a Russian-based pharmaceutical industry strong enough to be more independent of the West. This is exactly what President Medvedev has called for, offering tax relief and other economic support to encourage rapid development. The goal is…